Teva Pharmaceutical Industries (TEVA) Preferred Shares (2015 - 2018)

Teva Pharmaceutical Industries (TEVA) has reported Preferred Shares for 4 consecutive years, with $3.8 billion the latest figure, recorded in Q3 2018.

• For the quarter ending Q3 2018, Preferred Shares rose 5.66% year-over-year to $3.8 billion; the trailing twelve-month figure through Sep 2018 stood at $3.8 billion (up 5.66% YoY), and the FY2017 full-year result was $3.6 billion, changed 0.3% from the prior year.
• Preferred Shares climbed to $3.8 billion in Q3 2018 per TEVA's latest filing, from $3.8 billion in the prior quarter.
• Across five years, Preferred Shares topped out at $3.8 billion in Q3 2018 and bottomed at $3.3 billion in Q4 2015.
• Historically, Preferred Shares has averaged $3.6 billion across 4 years, with a median of $3.6 billion in 2016.
• The sharpest annual moves came in 2016 and 2017: Preferred Shares climbed 10.0% in 2016, then changed 0.0% in 2017.
• Over 4 years, Preferred Shares stood at $3.3 billion in 2015, then advanced by 10.0% to $3.6 billion in 2016, then grew by 0.3% to $3.6 billion in 2017, then gained by 5.34% to $3.8 billion in 2018.
• According to Business Quant data, Preferred Shares over the past three periods registered $3.8 billion, $3.8 billion, and $3.7 billion for Q3 2018, Q2 2018, and Q1 2018 respectively.